| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 129,204 | 90,687 | ||
| Restricted cash | 294 | 549 | ||
| Accounts receivable, net of allowance for credit losses of 3,845 and 7,454 as of september 30, 2025 and december31, 2024, respectively | 79,515 | 79,561 | ||
| Unbilled receivables | 54,093 | 51,576 | ||
| Prepaid expenses and other current assets | 54,093 | 46,125 | ||
| Due from related party | 13 | 7 | ||
| Total current assets | 317,212 | 268,505 | ||
| Property and equipment, net | 3,602 | 3,880 | ||
| Internal use software, net | 61,714 | 59,923 | ||
| Intangible assets, net | 115,631 | 124,204 | ||
| Goodwill | 677,635 | 677,752 | ||
| Operating lease right-of-use assets, net | 20,583 | 23,076 | ||
| Deferred tax asset, net | 2,439 | 6,198 | ||
| Other long-term assets | 9,002 | 8,711 | ||
| Total assets | 1,207,818 | 1,172,249 | ||
| Accounts payable and accrued expenses | 58,447 | 60,765 | ||
| Operating lease liabilities, current | 11,357 | 11,660 | ||
| Due to related party | 4 | 2 | ||
| Deferred revenue | 1,834 | 1,251 | ||
| Total current liabilities | 71,642 | 73,678 | ||
| Deferred tax liability, net | 8,991 | 0 | ||
| Long-term debt, net | 0 | 0 | ||
| Operating lease liabilities, non-current | 13,421 | 16,143 | ||
| Other long-term liabilities | 8,808 | 8,810 | ||
| Total liabilities | 102,862 | 98,631 | ||
| Common stock, 0.001 par value, 500,000,000 shares authorized, 166,863,690 and 162,871,266 shares issued and outstanding at september 30, 2025 and december31, 2024, respectively | 166 | 165 | ||
| Additional paid-in-capital | 1,025,055 | 1,000,857 | ||
| Accumulated other comprehensive income (loss) | 1,540 | 1,446 | ||
| Retained earnings | 78,195 | 71,150 | ||
| Total stockholders equity | 1,104,956 | 1,073,618 | ||
| Total liabilities and stockholders equity | 1,207,818 | 1,172,249 | ||
INTEGRAL AD SCIENCE HOLDING CORP. (IAS)
INTEGRAL AD SCIENCE HOLDING CORP. (IAS)